$AMRN
AMARIN CORP PLC\UK

2019 Q2 Form 10-Q Financial Statement

#000156459019027188 Filed on July 31, 2019

View on sec.gov

Income Statement

Concept 2019 Q2
Revenue $100.8M
YoY Change 91.46%
Cost Of Revenue $22.77M
YoY Change 77.25%
Gross Profit $78.02M
YoY Change 96.05%
Gross Profit Margin 77.41%
Selling, General & Admin $73.41M
YoY Change 36.19%
% of Gross Profit 94.08%
Research & Development $7.130M
YoY Change -60.82%
% of Gross Profit 9.14%
Depreciation & Amortization $162.0K
YoY Change 1.25%
% of Gross Profit 0.21%
Operating Expenses $80.54M
YoY Change 11.7%
Operating Profit -$2.514M
YoY Change -92.22%
Interest Expense $789.0K
YoY Change -144.5%
% of Operating Profit
Other Income/Expense, Net -$95.00K
YoY Change -5.0%
Pretax Income -$1.820M
YoY Change -94.68%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.820M
YoY Change -94.68%
Net Earnings / Revenue -1.81%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 330.9M
Diluted Shares Outstanding 330.9M

Balance Sheet

Concept 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $221.8M
YoY Change 116.78%
Cash & Equivalents $221.8M
Short-Term Investments
Other Short-Term Assets $8.606M
YoY Change 145.89%
Inventory $46.27M
Prepaid Expenses
Receivables $95.40M
Other Receivables $0.00
Total Short-Term Assets $372.0M
YoY Change 89.7%
LONG-TERM ASSETS
Property, Plant & Equipment $858.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.102M
YoY Change 451.0%
Total Long-Term Assets $17.92M
YoY Change 124.03%
TOTAL ASSETS
Total Short-Term Assets $372.0M
Total Long-Term Assets $17.92M
Total Assets $389.9M
YoY Change 91.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.02M
YoY Change -1.4%
Accrued Expenses $103.5M
YoY Change 40.24%
Deferred Revenue $1.962M
YoY Change 85.8%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $45.41M
YoY Change 59.89%
Total Short-Term Liabilities $184.9M
YoY Change 34.36%
LONG-TERM LIABILITIES
Long-Term Debt $23.20M
YoY Change -73.84%
Other Long-Term Liabilities $6.813M
YoY Change -72.19%
Total Long-Term Liabilities $30.02M
YoY Change -73.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $184.9M
Total Long-Term Liabilities $30.02M
Total Liabilities $240.8M
YoY Change -3.97%
SHAREHOLDERS EQUITY
Retained Earnings -$1.415B
YoY Change
Common Stock $250.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.53M
YoY Change
Treasury Stock Shares $3.842M
Shareholders Equity $149.1M
YoY Change
Total Liabilities & Shareholders Equity $389.9M
YoY Change 91.04%

Cashflow Statement

Concept 2019 Q2
OPERATING ACTIVITIES
Net Income -$1.820M
YoY Change -94.68%
Depreciation, Depletion And Amortization $162.0K
YoY Change 1.25%
Cash From Operating Activities $15.91M
YoY Change -165.12%
INVESTING ACTIVITIES
Capital Expenditures -$801.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$801.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.425M
YoY Change 87.5%
NET CHANGE
Cash From Operating Activities 15.91M
Cash From Investing Activities -801.0K
Cash From Financing Activities -4.425M
Net Change In Cash 10.68M
YoY Change -139.88%
FREE CASH FLOW
Cash From Operating Activities $15.91M
Capital Expenditures -$801.0K
Free Cash Flow $16.71M
YoY Change -168.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2019Q2 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.1
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17344000
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2019Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
amrn:AccruedLiabilitiesAndOtherLiabilitiesCurrent
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17344000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity File Number
EntityFileNumber
000-21392
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
221771000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1503000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95398000
CY2019Q2 us-gaap Inventory Net
InventoryNet
46268000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7103000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
372043000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
858000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8762000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1102000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7157000
CY2019Q2 us-gaap Assets
Assets
389922000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
34018000
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address Address Line2
EntityAddressAddressLine2
Block C
dei Entity Address Address Line3
EntityAddressAddressLine3
Grand Canal Docklands
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2
dei Entity Address Country
EntityAddressCountry
Ireland
dei Entity Address Address Line1
EntityAddressAddressLine1
77 Sir John Rogerson’s Quay
dei City Area Code
CityAreaCode
353 (0) 1
dei Local Phone Number
LocalPhoneNumber
6699 020
CY2019Q2 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
103495000
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
45410000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1962000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
184885000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23202000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17775000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8160000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6813000
CY2019Q2 us-gaap Liabilities
Liabilities
240835000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
289317460
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
289317460
CY2019Q2 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
28931746
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
21850000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
335149425
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
331307810
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
250588000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1311965000
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3841615
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
20533000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1414783000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
149087000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
389922000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7130000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6596000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
80536000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2514000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
789000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-95000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1820000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
330863000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330863000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
152330000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15456000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9080000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-24431000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
140871000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
837000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1888000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1040000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8351000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1820000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
149087000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-65100000
CY2018Q1 amrn Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-65318000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
70007000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1548000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2553000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3754000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11000
us-gaap Share Based Compensation
ShareBasedCompensation
14766000
us-gaap Share Based Compensation
ShareBasedCompensation
7381000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
878000
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
423000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
278000
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-127000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3606000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-34210000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-46687000
us-gaap Profit Loss
ProfitLoss
-26251000
us-gaap Profit Loss
ProfitLoss
-58305000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-24095000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-16657000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1140000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
323000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
323000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28875000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4991000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11534000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9833000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4158000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-577000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
928000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-58000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3186000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22180000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34243000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
837000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12533000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6713000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10120000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2680000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62863000
amrn Initial Recognition Of Operating Lease Right Of Use Asset
InitialRecognitionOfOperatingLeaseRightOfUseAsset
8995000
amrn Number Of Patients Enrolled And Randomized In Study
NumberOfPatientsEnrolledAndRandomizedInStudy
8179
amrn Number Of Sales Professionals
NumberOfSalesProfessionals
800
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q2 us-gaap Assets Current
AssetsCurrent
372000000.0
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
221800000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95400000
CY2019Q2 us-gaap Inventory Net
InventoryNet
46300000
CY2019Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
0
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2019Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
116262000
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
86133000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95398000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66523000
CY2019Q2 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-1820000
CY2018Q2 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-34210000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-26251000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-58305000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
330863000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
293662000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
329793000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
289458000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Concentration of Credit Risk</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in financial institutions believed to be of high-credit quality.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. Three customers individually accounted for 10% or more of the Company’s gross product sales. Customers A, B, and C accounted for 24%, 37%, and 29%, respectively, of gross product sales for the six months ended June 30, 2019, and represented 38%, 32%, and 22%, respectively, of the gross accounts receivable balance as of June 30, 2019. Customers A, B, and C accounted for 27%, 31%, and 31%, respectively, of gross product sales for the six months ended June 30, 2018 and represented 33%, 37%, and 22%, respectively, of the gross accounts receivable balance as of June 30, 2018. The Company has not experienced any significant write-offs of its accounts receivable.</p>
CY2019Q2 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
44852000
CY2018Q4 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
33602000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23202000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46108000
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
68054000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
79710000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P11Y1M6D
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4467000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4144000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7157000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7480000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3845000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
8590000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6573000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14142000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
36008000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35357000
CY2019Q2 us-gaap Inventory Gross
InventoryGross
46426000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
58089000
CY2019Q2 us-gaap Inventory Adjustments
InventoryAdjustments
158000
CY2018Q4 us-gaap Inventory Adjustments
InventoryAdjustments
287000
CY2019Q2 us-gaap Inventory Net
InventoryNet
46268000
CY2018Q4 us-gaap Inventory Net
InventoryNet
57802000
CY2019Q2 us-gaap Purchase Obligation
PurchaseObligation
90000000.0
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q1 amrn Private Placement Closing Date
PrivatePlacementClosingDate
2015-03-30
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
52800000
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2015Q1 us-gaap Share Price
SharePrice
2.39
CY2015Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
31300000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16585065
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4458143
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
956232
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1800000
CY2019Q2 amrn Cash Discount Percent
CashDiscountPercent
0.02
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
222028000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
134337000
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18806000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
62358000
CY2019Q2 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
90577000
CY2017Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
48093000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
106853000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
1305000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
56177000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
34647000
CY2018Q2 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
62817000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20710000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
973000
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19737000
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19054000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
248000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
973000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
248000
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
amrn Operating Lease Change In Weighted Average Discount Rate Percent
OperatingLeaseChangeInWeightedAverageDiscountRatePercent
0.01
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
200000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9300000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1100000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8800000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
738000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1587000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1784000
CY2019Q2 amrn Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
1818000
CY2019Q2 amrn Lessee Operating Lease Liability Payments Due Year Seven And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearSevenAndThereafter
12297000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18224000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8938000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1126000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8160000

Files In Submission

Name View Source Status
0001564590-19-027188-index-headers.html Edgar Link pending
0001564590-19-027188-index.html Edgar Link pending
0001564590-19-027188.txt Edgar Link pending
0001564590-19-027188-xbrl.zip Edgar Link pending
amrn-10q_20190630.htm Edgar Link pending
amrn-10q_20190630_htm.xml Edgar Link completed
amrn-20190630.xsd Edgar Link pending
amrn-20190630_cal.xml Edgar Link unprocessable
amrn-20190630_def.xml Edgar Link unprocessable
amrn-20190630_lab.xml Edgar Link unprocessable
amrn-20190630_pre.xml Edgar Link unprocessable
amrn-ex101_101.htm Edgar Link pending
amrn-ex102_257.htm Edgar Link pending
amrn-ex103_324.htm Edgar Link pending
amrn-ex104_258.htm Edgar Link pending
amrn-ex311_8.htm Edgar Link pending
amrn-ex312_7.htm Edgar Link pending
amrn-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gcr5ttkx5n21000001.jpg Edgar Link pending
gcr5ttkx5n21000002.jpg Edgar Link pending
gjoio25pcnup000001.jpg Edgar Link pending
gy1wut32rid1000001.jpg Edgar Link pending
gy1wut32rid1000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending